John Bissell, the CEO and Director of $ORGN, sold 45,000 shares of the company on 12-19-2025 for an estimated $12,078. We received data on the trade from a recent SEC filing. This was a sale of approximately 2.2% of their shares of this class of stock. Following this trade, they now own 1,997,973 shares of this class of $ORGN stock.
$ORGN Insider Trading Activity
$ORGN insiders have traded $ORGN stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $ORGN stock by insiders over the last 6 months:
- MATTHEW T PLAVAN (CFO and COO) sold 150,000 shares for an estimated $82,500
- JOHN BISSELL (CEO and Director) sold 45,000 shares for an estimated $12,078
- JOSHUA C. LEE (General Counsel) has made 0 purchases and 2 sales selling 22,060 shares for an estimated $8,749.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ORGN Hedge Fund Activity
We have seen 25 institutional investors add shares of $ORGN stock to their portfolio, and 56 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS GROUP AG removed 935,928 shares (-97.4%) from their portfolio in Q3 2025, for an estimated $485,372
- REHMANN CAPITAL ADVISORY GROUP removed 611,332 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $295,395
- JACOBS LEVY EQUITY MANAGEMENT, INC added 557,747 shares (+848.8%) to their portfolio in Q3 2025, for an estimated $289,247
- SUSQUEHANNA INTERNATIONAL GROUP, LLP added 378,166 shares (+86.8%) to their portfolio in Q3 2025, for an estimated $196,116
- RENAISSANCE TECHNOLOGIES LLC removed 367,100 shares (-72.1%) from their portfolio in Q3 2025, for an estimated $190,378
- ACADIAN ASSET MANAGEMENT LLC removed 334,977 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $161,860
- CITADEL ADVISORS LLC added 251,408 shares (+260.3%) to their portfolio in Q3 2025, for an estimated $130,380
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$ORGN Revenue
$ORGN had revenues of $4.7M in Q3 2025. This is a decrease of -43.22% from the same period in the prior year.
You can track ORGN financials on Quiver Quantitative's ORGN stock page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
